134 related articles for article (PubMed ID: 7778073)
41. Haemophilus B polysaccharide vaccine. Antibody kinetics in 17- to 71-month-old children.
Ramsey KP; Popejoy LA; Jesse SW; Gonzales-Torres I
Am J Dis Child; 1989 Jan; 143(1):28-30. PubMed ID: 2910043
[TBL] [Abstract][Full Text] [Related]
42. Hib immunisation catch up programme in North East Thames.
O'Brien H
Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R17-8. PubMed ID: 7511460
[No Abstract] [Full Text] [Related]
43. [Trial of prevention of severe Haemophilus influenzae type b infections and trial of tolerance, after PRP-T vaccination, in the Val-de-Marne region].
Boucher J; Ethevenaux C; Guyot C; Leroux MC; Fritzell B; Saliou P; Reinert P
Arch Pediatr; 1996 Aug; 3(8):775-81. PubMed ID: 8998530
[TBL] [Abstract][Full Text] [Related]
44. Fragmentation of scheduled visits and missed doses among infants receiving multiple injected vaccines.
Ferson MJ; McKenzie KA; Macartney-Bourne F
Aust N Z J Public Health; 1997 Dec; 21(7):735-8. PubMed ID: 9489191
[TBL] [Abstract][Full Text] [Related]
45. [Immunological principles of polysaccharide-protein conjugate vaccination].
Meyer M; Gahr M
Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for invasive Haemophilus influenzae disease among children 2-16 years of age in the vaccine era, Switzerland 1991-1993. The Swiss H. Influenzae Study Group.
Mühlemann K; Alexander ER; Weiss NS; Pepe M; Schopfer K
Int J Epidemiol; 1996 Dec; 25(6):1280-5. PubMed ID: 9027536
[TBL] [Abstract][Full Text] [Related]
47. Use of vaccines and antibiotic prophylaxis in contacts and cases of Haemophilus influenzae type b (Hib) disease.
Cartwright KA; Begg NT; Rudd PT
Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R16-7. PubMed ID: 7511459
[No Abstract] [Full Text] [Related]
48. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine.
Peters VB; Sood SK
J Pediatr; 1994 Jul; 125(1):74-7. PubMed ID: 8021791
[TBL] [Abstract][Full Text] [Related]
49. Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia.
Sarnaik S; Kaplan J; Schiffman G; Bryla D; Robbins JB; Schneerson R
Pediatr Infect Dis J; 1990 Mar; 9(3):181-6. PubMed ID: 2336298
[TBL] [Abstract][Full Text] [Related]
50. [Vaccination against Haemophilus influenzae B and rubella].
Windorfer A
Gesundheitswesen; 1992 Oct; 54(10):528-34. PubMed ID: 1450535
[TBL] [Abstract][Full Text] [Related]
51. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants.
Clements-Mann ML; Dudas R; Hoshino Y; Nehring P; Sperber E; Wagner M; Stephens I; Karron R; Deforest A; Kapikian AZ
Vaccine; 2001 Sep; 19(32):4676-84. PubMed ID: 11535316
[TBL] [Abstract][Full Text] [Related]
52. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
Käyhty H; Karanko V; Peltola H; Mäkelä PH
Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614
[TBL] [Abstract][Full Text] [Related]
53. Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection.
Gibb D; Giacomelli A; Masters J; Spoulou V; Ruga E; Griffiths H; Kroll S; Giaquinto C; Goldblatt D
Pediatr Infect Dis J; 1996 Dec; 15(12):1097-101. PubMed ID: 8970219
[TBL] [Abstract][Full Text] [Related]
54. Effect of the DTwP Haemophilus influenzae b conjugate vaccination in Mexico (1999-2007).
Gómez de León Cruces P; Díaz García J; Santos JI
Arch Med Res; 2010 May; 41(4):281-7. PubMed ID: 20637372
[TBL] [Abstract][Full Text] [Related]
55. Three-dose vaccination of infants under 8 months of age with a conjugate Haemophilus influenzae type B vaccine.
Rowe JE; Messinger IK; Schwendeman CA; Popejoy LA
Mil Med; 1990 Oct; 155(10):483-6. PubMed ID: 2122290
[TBL] [Abstract][Full Text] [Related]
56. Haemophilus influenzae type b: the search for a vaccine.
Robbins JB; Schneerson R
Pediatr Infect Dis J; 1987 Aug; 6(8):791-4. PubMed ID: 3313243
[TBL] [Abstract][Full Text] [Related]
57. FDA Committee recommends combined DTP, Haemophilus influenzae vaccine.
Marwick C
JAMA; 1992 Dec 23-30; 268(24):3415. PubMed ID: 1334159
[No Abstract] [Full Text] [Related]
58. Reaction of the sera of the Korean children free from Hib invasive diseases against H. influenzae type B capsular polysaccharide antigen.
Kim KH; Kim DS; Park MS; Kim KT; Kim HS; Kim KH; Kwon OH
J Korean Med Sci; 1994 Feb; 9(1):1-8. PubMed ID: 8068214
[TBL] [Abstract][Full Text] [Related]
59. Hib vaccine is available and soon to be required.
Kelley MF
Tex Med; 1991 Jan; 87(1):8. PubMed ID: 1998163
[No Abstract] [Full Text] [Related]
60. [Haemophilus influenzae meningitis in Austria: 1990-1992 incidence].
Vutuc C; Kunze M
Wien Klin Wochenschr; 1995; 107(8):256-7. PubMed ID: 7762246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
